Clinical Research

Factors influencing number of lymph nodes obtained by prophylactic central lymph node dissection for papillary thyroid cancer

  • Keyi LIU ,
  • Guangpeng LIANG ,
  • Fang CHAI ,
  • Chang. LIU
Expand
  • *.Department of Thyroid Surgery,the First Affiliated Hospital of Jinzhou Medical University,Jinzhou 121000,China

Received date: 2023-08-25

  Online published: 2024-03-08

Abstract

Objective To investigate the factors affecting the number of lymph nodes obtained by unilateral lobectomy and isthmus combined with prophylactic ipsilateral central lymph node dissection for papillary thyroid cancer, and to analyze the pattern of change so as to provide an important basis for clinical treatment of papillary thyroid cancer. Methods Retrospective analysis was performed on the clinical and pathological data of 193 patients admitted to the department of Thyroid Surgery of the First Affiliated Hospital of Jinzhou Medical University from January 2019 to January 2022 for papillary thyroid cancer who underwent unilateral glandular lobe and isthmus resection combined with prophylactic ipsilateral central lymph node dissection. The number of obtained lymph nodes was divided into a group with high number of obtained lymph nodes(n > 6)and a group with low number of obtained lymph nodes(n ≤ 6). Univariate analysis and multivariate analysis were used to explore the factors affecting the number of obtained lymph nodes. The influence of the number of lymph nodes on the central lymph node metastasis was evaluated by correlation analysis, and the influence of the number of lymph nodes on the quality of life of patients by postoperative complications analysis. Results The number of lymph nodes obtained was positively correlated with the number of lymph node metastases in the central region(r = 0.240,P < 0.05)and the rate of lymph node metastasis(r = 0.161,P < 0.05), respectively. The number of lymph node metastases controlled remained unchanged,and the rate of lymph node metastasis decreased with the increase of the number of obtained lymph nodes(r = -0.444,P < 0.05). Univariate analysis of the number of lymph nodes between the two groups showed no significant differences in terms of sex, age, operation duration, BMI, maximum tumor diameter, multifocality, Hashimoto′s thyroiditis, focal location, capsular invasion, contralateral thyroid nodule, parathyroid transplantation and BRAF gene V600E mutation(P > 0.05). There was statistical significance in the application of nano carbon between the two groups(P < 0.05). Logistic binary regression analysis showed that the combination of Hashimoto′s thyroiditis and the application of carbon nanoparticles were independent influencing factors for the high number of lymph nodes obtained(P < 0.05). ROC curve analysis suggested that the area under the curve occupied by carbon nanoscale was 0.658(95%CI:0.580 ~ 0.735, P < 0.05), and the area under the curve occupied by Hashimoto′s thyroiditis was 0.584(95%CI:0.504 ~ 0.665,P < 0.05). In addition, there was no significant difference in the incidence of vocal cord paralysis and lymphatic leakage between the two groups (P > 0.05). Conclusions When the number of lymph nodes in the central region remained unchanged, the higher the number of lymph nodes obtained, the lower the rate of lymph node metastasis. The application of nano?carbon and patients with Hashimoto′s thyroiditis could increase the number of lymph nodes obtained, and there is no significant difference in the incidence of postoperative complications between high and low number of lymph nodes obtained.

Cite this article

Keyi LIU , Guangpeng LIANG , Fang CHAI , Chang. LIU . Factors influencing number of lymph nodes obtained by prophylactic central lymph node dissection for papillary thyroid cancer[J]. The Journal of Practical Medicine, 2024 , 40(4) : 508 -514 . DOI: 10.3969/j.issn.1006-5725.2024.04.012

References

1 AMIN S N, SHINN J R, NAGUIB M M, et al. Risk Factors and Outcomes of Postoperative Recurrent Well-Differentiated Thyroid Cancer: A Single Institution's 15-Year Experience[J]. Otolaryngol Head Neck Surg, 2020, 162(4):469-475. doi:10.1177/0194599820904923
2 GROGAN R H, KAPLAN S P, CAO H, et al. A study of recurrence and death from papillary thyroid cancer with 27 years of median follow-up[J]. Surgery, 2013, 154(6):1436-1446. doi:10.1016/j.surg.2013.07.008
3 中华人民共和国国家卫生健康委员会医政医管局. 甲状腺癌诊疗指南(2022年版)[J]. 中国实用外科杂志,2022,42(12):1343-1363.
4 高婕,辛运超,杨立航,等. 甲状腺乳头状癌跳跃性颈侧区淋巴结转移的危险因素分析[J]. 临床耳鼻咽喉头颈外科杂志,2022,36(7):528-532.
5 董文武,张浩. 甲状腺乳头状癌淋巴清扫获得淋巴结数量的影响因素及临床价值研究进展[J].中华耳鼻咽喉头颈外科杂志,2020,55(8):795-798. doi:10.3760/cma.j.cn115330-20200401-00258
6 董凌翔,贺亮,张浩,等. 甲状腺癌中央区淋巴结清扫术后并发乳糜漏14例临床分析[J]. 中国实用外科杂志,2019,39(2):173-177.
7 邵长秀,贺青卿,庄晓璇,等. 934例甲状腺微小乳头状癌颈淋巴结部位转移及危险因素[J]. 山东大学学报(医学版),2023,61(2):57-64.
8 王欢,柴芳,林本瑞,等. 合并桥本甲状腺炎的甲状腺乳头状癌中央区淋巴结转移的危险因素[J]. 中国老年学杂志,2021,41(7):1396-1399. doi:10.3969/j.issn.1005-9202.2021.07.015
9 李文惠,于玮莹,隋国庆,等. 多灶性甲状腺微小乳头状癌颈部淋巴结转移预测模型的建立与评估[J]. 中国实验诊断学,2022,26(10):1467-1472.
10 FENG Y, MIN Y, CHEN H, et al. Construction and validation of a nomogram for predicting cervical lymph node metastasis in classic papillary thyroid carcinoma[J]. J Endocrinol Invest, 2021, 44(10):2203-2211. doi:10.1007/s40618-021-01524-5
11 CHUNG E J, CHO S J, PARK M W, et al. The impact of the number of harvested central lymph nodes on the lymph node ratio[J]. Auris Nasus Larynx, 2019, 46(2):267-271. doi:10.1016/j.anl.2018.08.005
12 刘承开,张蕾,王晓东. 基于C-TIRADS分析甲状腺乳头状癌出现颈部淋巴结转移的影响因素[J]. 实用医学杂志,2021,37(12):1587-1591.
13 徐思源,任忠峰,刘杰,等. 中央区淋巴结转移甲状腺乳头状癌患者侧颈淋巴结复发风险预测模型的构建[J]. 中华肿瘤杂志,2021,43(7):775-780. doi:10.3760/cma.j.cn112152-20190314-00161
14 蔡卉珠,黄泽浩,黄樱城,等. 甲状腺乳头状癌侧颈淋巴结转移的诊疗现状[J]. 中华耳鼻咽喉头颈外科杂志, 2023,58(4):398-402. doi:10.3760/cma.j.cn115330-20221018-00617
15 ANDRE Y C, HUGO F K, CAMILA C G, et al. Predictive factors for recurrence of papillary thyroid carcinoma:analysis of 4,085 patients[J]. Acta Otorhinolaryngol Ital, 2021, 41(3):236-242. doi:10.14639/0392-100x-n1412
16 HU J Q, WEN D, MA B, et al. The extent of lymph node yield in central neck dissection can be affected by preoperative and intraoperative assessment and alter the prognosis of papillary thyroid carcinoma[J]. Cancer Med, 2020, 9(3):1017-1024. doi:10.1002/cam4.2762
17 吴天琦,张静. 纳米碳在甲状腺乳头状癌术中的应用进展[J]. 实用医学杂志, 2023,39(8):1063-1066. doi:10.3969/j.issn.1006-5725.2023.08.025
18 朱江,那将超,田国标,等. 纳米炭在甲状腺乳头状癌淋巴结清扫中的价值及对术后甲状旁腺激素的影响[J]. 中国耳鼻咽喉头颈外科, 2022,29(3):141-145.
19 WU W X, FENG J W, YE J, et al. Influence of Obesity Parameters on Different Regional Patterns of Lymph Node Metastasis in Papillary Thyroid Cancer[J]. Int J Endocrinol, 2022, 2022:3797955. doi:10.1155/2022/3797955
20 TAO Y B, WANG F, SHEN X P, et al. BRAF V600E Status Sharply Differentiates Lymph Node Metastasis-associated Mortality Risk in Papillary Thyroid Cancer[J]. J Clin Endocrinol Metab, 2021, 106(11):3228-3238. doi:10.1210/clinem/dgab286
21 郑王虎,李超,孙荣昊,等. cN0甲状腺乳头状癌中央区淋巴结亚区清扫的研究进展[J]. 中华耳鼻咽喉头颈外科杂志, 2020,55(8):799-803. doi:10.3760/cma.j.cn115330-20200411-00289
22 DAVID D D, ALEXEY V S, ROBERT B M, et al. A narrative review of preventive central lymph node dissection in patients with papillary thyroid cancer:a necessity or an excess[J]. Front Oncol, 2022, 12:906695. doi:10.3389/fonc.2022.906695
23 GREGORY B, ARNAUD J, CAMILLE M, et al. Impact of lymph node dissection on postoperative complications of total thyroidectomy in patients with thyroid carcinoma[J]. Cancers(Basel), 2022, 14(21):5462. doi:10.3390/cancers14215462
24 ALQAHTANI S M, AL-SOHABI H R, RAYZAH M F, et al. Recurrent laryngeal nerve injury after thyroidectomy: A national study from Saudi Arabia[J]. Saudi Med J, 2023, 44(1):80-84. doi:10.15537/smj.2023.44.1.20220710
25 冯嘉麟,周秦毅,陈隽,等. 甲状腺癌中央区淋巴清扫术后乳糜漏的临床分析[J]. 中华耳鼻咽喉头颈外科杂志, 2019,54(8):597-600. doi:10.3760/cma.j.issn.1673-0860.2019.08.007
Outlines

/